BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 11102566)

  • 1. Mucins in the diagnosis and therapy of pancreatic cancer.
    Ho JJ
    Curr Pharm Des; 2000 Dec; 6(18):1881-96. PubMed ID: 11102566
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serological pancreatic tumor markers and the MUC1 apomucin.
    Ho JJ; Kim YS
    Pancreas; 1994 Nov; 9(6):674-91. PubMed ID: 7846010
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diagnostic value of mucins (MUC1, MUC2 and MUC5AC) expression profile in endoscopic ultrasound-guided fine-needle aspiration specimens of the pancreas.
    Wang Y; Gao J; Li Z; Jin Z; Gong Y; Man X
    Int J Cancer; 2007 Dec; 121(12):2716-22. PubMed ID: 17708554
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mucins in pancreatic cancer: A well-established but promising family for diagnosis, prognosis and therapy.
    Wang S; You L; Dai M; Zhao Y
    J Cell Mol Med; 2020 Sep; 24(18):10279-10289. PubMed ID: 32745356
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Multiple roles of mucins in pancreatic cancer, a lethal and challenging malignancy.
    Moniaux N; Andrianifahanana M; Brand RE; Batra SK
    Br J Cancer; 2004 Nov; 91(9):1633-8. PubMed ID: 15494719
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MUC1 and the MUCs: a family of human mucins with impact in cancer biology.
    Baldus SE; Engelmann K; Hanisch FG
    Crit Rev Clin Lab Sci; 2004; 41(2):189-231. PubMed ID: 15270554
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Purification and characterization of a human pancreatic adenocarcinoma mucin.
    Khorrami AM; Choudhury A; Andrianifahanana M; Varshney GC; Bhattacharyya SN; Hollingsworth MA; Kaufman B; Batra SK
    J Biochem; 2002 Jan; 131(1):21-9. PubMed ID: 11754731
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterization of new pancreatic cancer-reactive monoclonal antibodies directed against purified mucin.
    Ho JJ; Bi N; Yan PS; Yuan M; Norton KA; Kim YS
    Cancer Res; 1991 Jan; 51(1):372-80. PubMed ID: 1703039
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Analysis of mucins: role in laboratory diagnosis.
    Mall AS
    J Clin Pathol; 2008 Sep; 61(9):1018-24. PubMed ID: 18641408
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Multiple forms of intracellular and secreted mucins in a pancreatic cancer cell line.
    Ho JJ; Bi N; Siddiki B; Chung YS; Yuan M; Kim YS
    Cancer Res; 1993 Feb; 53(4):884-90. PubMed ID: 7679052
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Carcinoma associated mucins: molecular biology and clinical applications.
    Verma M
    Cancer Biochem Biophys; 1994 Oct; 14(3):151-62. PubMed ID: 7728736
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mucin-based targeted pancreatic cancer therapy.
    Torres MP; Chakraborty S; Souchek J; Batra SK
    Curr Pharm Des; 2012; 18(17):2472-81. PubMed ID: 22372499
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cystic fibrosis and pancreatic cancer cells synthesize and secrete MUC1 type mucin gene product.
    Dahiya R; Kwak KS; Ho SB; Yoon WH; Kim YS
    Biochem Mol Biol Int; 1995 Feb; 35(2):351-62. PubMed ID: 7545050
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression of MUC1 and MUC2 mucins by human tumor cell lines.
    Devine PL; Birrell GW; Whitehead RH; Harada H; Xing PX; McKenzie IF
    Tumour Biol; 1992; 13(5-6):268-77. PubMed ID: 1283926
    [TBL] [Abstract][Full Text] [Related]  

  • 15. RNA interference suppression of MUC1 reduces the growth rate and metastatic phenotype of human pancreatic cancer cells.
    Tsutsumida H; Swanson BJ; Singh PK; Caffrey TC; Kitajima S; Goto M; Yonezawa S; Hollingsworth MA
    Clin Cancer Res; 2006 May; 12(10):2976-87. PubMed ID: 16707592
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association of sialyl-Lewis(a) and sialyl-Lewis(x) with MUC-1 apomucin ina pancreatic cancer cell line.
    Ho JJ; Siddiki B; Kim YS
    Cancer Res; 1995 Aug; 55(16):3659-63. PubMed ID: 7627976
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mucin (MUC) gene expression in human pancreatic adenocarcinoma and chronic pancreatitis: a potential role of MUC4 as a tumor marker of diagnostic significance.
    Andrianifahanana M; Moniaux N; Schmied BM; Ringel J; Friess H; Hollingsworth MA; Büchler MW; Aubert JP; Batra SK
    Clin Cancer Res; 2001 Dec; 7(12):4033-40. PubMed ID: 11751498
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MUC1 and MUC2 in pancreatic neoplasia.
    Levi E; Klimstra DS; Andea A; Basturk O; Adsay NV
    J Clin Pathol; 2004 May; 57(5):456-62. PubMed ID: 15113850
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunohistochemical study of mucin carbohydrates and core proteins in human pancreatic tumors.
    Osako M; Yonezawa S; Siddiki B; Huang J; Ho JJ; Kim YS; Sato E
    Cancer; 1993 Apr; 71(7):2191-9. PubMed ID: 8384065
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The expression of several types of mucin is related to the biological behavior of pancreatic neoplasms.
    Yonezawa S; Nakamura A; Horinouchi M; Sato E
    J Hepatobiliary Pancreat Surg; 2002; 9(3):328-41. PubMed ID: 12353144
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.